The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so if a woman is um in her let's say late 30s um she is anticipating perimenopause maybe is in per menopause and wants to start lowd dose um hormone replacement therapy I think it's something um worth mentioned that not all you know presumably the dosages are tailored and then blood so a given dose is tried blood is drawn you measure estradi
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.